Clinical trial
Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment…
NCT00296257 · Dainippon Sumitomo Pharma Europe LTd., Industry · Terminated
Key facts
| NCT number | NCT00296257 |
|---|---|
| Title | Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114 |
| Official title | A Phase 2, Multi-Centre, Randomised, Double Blind, Placebo Controlled Study Evaluating the Efficacy, Safety and Pharmacokinetics of Two Doses of a Candidate Disease Modifying Anti-Rheumatic Drug (DMARD), (SMP-114 120 mg and 240 mg Once Daily), Administered in Combination With Ongoing Methotrexate… |
| Lead sponsor | Dainippon Sumitomo Pharma Europe LTd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis (RA) |
| Intervention type | Drug |
| Interventions | SMP-114 |
| Enrollment | 312 |
| Start date | Feb 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Feb 24, 2006 |
| Last update posted | Mar 13, 2009 |
| Countries | Czechia, Germany, Hungary, Netherlands, Poland, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: